PURPOSE: To describe effective retention strategies in a clinical trial with a high risk, low-income, and vulnerable patient population with serious mental illness. DESIGN: Follow-up assessments were conducted for a randomized clinical tobacco treatment trial at 3, 6, and 12 months postbaseline. Initial follow-up rates of <40% at 3 months led to implementation of proactive retention strategies including obtaining extensive contact information; building relationships with case managers and social workers; contacting jails and prisons; text messaging, e-mailing, and messaging via social networking sites; identifying appointments via electronic medical record; and field outreach to treatment facilities, residences, and parks. SETTING:Large urban public hospital. SUBJECTS:Participants were current smokers recruited from 100% smoke-free locked psychiatry units. MEASURES: Assessments covered demographics, substance use, and mental health functioning. ANALYSIS: Retention rates were plotted over time in relation to key retention strategies. Chi-square and t-tests were used to examine participant predictors of retention at each follow-up. At the 12-month follow-up, the retention strategies that most frequently led to assessment completion were identified. RESULTS:The sample (N = 100) was 65% male; age x = 39.5 years (SD = 11.3); 44% non-Hispanic white; 46% on Medicaid and 34% uninsured; 79% unemployed; and 48% unstably housed. Proactive retention strategies dramatically increased follow-up rates, concluding at 3 months = 82.65%, 6 months = 89.69%, and 12 months = 92.78%. Married and divorced/separated/widowed participants, those with higher income, and participants with alcohol or illicit drug problems had increased retention from 3- to 12-month follow-up. CONCLUSION: Follow-up rates improved as proactive methods to contact participants were implemented. Dedicated research staff, multiple methods, community networking, and outreach within drug treatment settings improved retention.
RCT Entities:
PURPOSE: To describe effective retention strategies in a clinical trial with a high risk, low-income, and vulnerable patient population with serious mental illness. DESIGN: Follow-up assessments were conducted for a randomized clinical tobacco treatment trial at 3, 6, and 12 months postbaseline. Initial follow-up rates of <40% at 3 months led to implementation of proactive retention strategies including obtaining extensive contact information; building relationships with case managers and social workers; contacting jails and prisons; text messaging, e-mailing, and messaging via social networking sites; identifying appointments via electronic medical record; and field outreach to treatment facilities, residences, and parks. SETTING: Large urban public hospital. SUBJECTS:Participants were current smokers recruited from 100% smoke-free locked psychiatry units. MEASURES: Assessments covered demographics, substance use, and mental health functioning. ANALYSIS: Retention rates were plotted over time in relation to key retention strategies. Chi-square and t-tests were used to examine participant predictors of retention at each follow-up. At the 12-month follow-up, the retention strategies that most frequently led to assessment completion were identified. RESULTS: The sample (N = 100) was 65% male; age x = 39.5 years (SD = 11.3); 44% non-Hispanic white; 46% on Medicaid and 34% uninsured; 79% unemployed; and 48% unstably housed. Proactive retention strategies dramatically increased follow-up rates, concluding at 3 months = 82.65%, 6 months = 89.69%, and 12 months = 92.78%. Married and divorced/separated/widowed participants, those with higher income, and participants with alcohol or illicit drug problems had increased retention from 3- to 12-month follow-up. CONCLUSION: Follow-up rates improved as proactive methods to contact participants were implemented. Dedicated research staff, multiple methods, community networking, and outreach within drug treatment settings improved retention.
Authors: Lisa M Nicholson; Patricia M Schwirian; Elizabeth G Klein; Theresa Skybo; Lisa Murray-Johnson; Ihuoma Eneli; Bethany Boettner; Gina M French; Judith A Groner Journal: Contemp Clin Trials Date: 2011-01-27 Impact factor: 2.226
Authors: Claire S Leathem; Margaret E Cupples; Mary C Byrne; Mary O'Malley; Ailish Houlihan; Andrew W Murphy; Susan M Smith Journal: BMC Med Res Methodol Date: 2009-06-19 Impact factor: 4.615
Authors: Shannon Self-Brown; Melissa C Osborne; Betty S Lai; Natasha De Veauuse Brown; Theresa L Glasheen; Melissa C Adams Journal: J Fam Violence Date: 2017-09-07
Authors: Leah N Torres; David K Turok; Jessica N Sanders; Janet C Jacobson; Amna I Dermish; Katherine Ward Journal: Contraception Date: 2014-08-01 Impact factor: 3.375
Authors: Stephanie H Yu; Nicole B Gumport; Isaac A Mirzadegan; Yuh-Jang Mei; Kerrie Hein; Allison G Harvey Journal: Behav Sleep Med Date: 2019-04-29 Impact factor: 3.492